Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Single-dose dexamethasone for mild-to-moderate asthma exacerbations

Effective, easy, and acceptable

Keith P. Cross, Ronald I. Paul and Ran D. Goldman
Canadian Family Physician October 2011, 57 (10) 1134-1136;
Keith P. Cross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald I. Paul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ran D. Goldman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rgoldman@cw.bc.ca
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Question I prescribe oral steroids for children in my community when they suffer asthma exacerbation. How many doses of steroids are recommended? Do all children need to take steroids for 5 days?

Answer Traditionally, mild-to-moderate pediatric asthma exacerbations have been treated with a short course of oral steroids—often 5 days of prednisone or prednisolone. However, recent evidence suggests a similar outcome can be acheived with a single dose of dexamethasone, which has a longer half-life and powerful anti-inflammatory effects, along with easier administration and compliance. Single-dose dexamethasone offers a simple and reliable treatment for these patients in office, urgent care, and emergency department settings.

Asthma is one of the most common reasons for children to present for acute evaluation. Some exacerbations warrant admission for inpatient care, but many can be managed effectively on an outpatient basis with a combination of avoiding environmental triggers, inhaled β-agonists, a short course of oral steroids, and close follow-up.

Traditionally, a short course of steroids (prednisone or prednisolone for 5 days) has been recommended.1 Still, there is growing evidence that a single dose of dexamethasone is not only easier to take and more acceptable to patients and their caregivers, but it is also equally effective.

Effectiveness

Two pediatric studies have compared the use of 2 doses of oral dexamethasone (day 1 and day 2) with 5 days of prednisone (or prednisolone). One study of 533 children reported 10-day relapse rates of 7.4% with dexamethasone versus 6.9% with prednisone (P = .84).2 The other study, which had 89 children, also noted no significant difference in 10-day relapse rates between the 2 groups (P = .27) and no significant difference in vomiting (5 of 51 with dexamethasone vs 7 of 38 with prednisone, P = .24).3

Single-dose dexamethasone regimens also have been compared with 3- or 5-day use of prednisone. Single-dose regimens are of greatest interest to health care providers in ambulatory care settings because of the potential to improve compliance, as has been documented in studies of a variety of other single-dose therapies.4 Besides better compliance, several other mechanisms might contribute to the effectiveness of single-dose dexamethasone. First, its half-life (approximately 36 to 54 hours) is approximately double that of prednisone (approximately 12 to 36 hours).5 Second, dexamethasone is generally thought to have 5 times the anti-inflammatory potency of prednisone; however, when compared against a larger dose of prednisone in recent studies, the difference in potency was less significant.6 Third, most of the asthma-improving effect of prednisone occurs in the first 3 days of treatment; the doses on days 4 and 5 appear to have little, if any, effect on outcome, which makes the effectiveness of a single dose of dexamethasone seem more reasonable.7

Intramuscular single dose

Three studies reported the use of a single dose of intramuscular (IM) dexamethasone. Klig et al8 conducted a pilot study with 42 children, half of whom received 0.3 mg/kg of IM dexamethasone (maximum 15 mg) once and half of whom received 2 mg/kg of oral prednisone (maximum 100 mg) for 3 days. The primary outcome measure was parental report of a lack of symptomatic improvement or the need for urgent care or hospital visits during the 5 days after enrolment, which occurred in only 2 of 21 dexamethasone patients versus 0 of 21 prednisone patients (P = .49). In a second study, Gries et al9 found similar improvements in clinical asthma scores within the first 5 days of therapy. This study contained a group of 15 children receiving a single dose of IM dexamethasone (1.7 mg/kg) and a group of 17 children receiving 5 doses of oral prednisone (2 mg/kg). In a third randomized trial, Gordon et al10 found similar asthma scores at 4 and 14 days among 126 children receiving either 1 dose of IM dexamethasone (0.6 mg/kg, maximum 15 mg) or 5 daily doses of prednisone (2 mg/kg, maximum 50 mg). Furthermore, a recent abstract described better parental satisfaction after a single dose of 0.6 mg/kg IM dexamethasone (maximum 15 mg) compared with 5 days of 2 mg/kg of oral prednisolone (maximum 60 mg).11

In these studies of mild-to-moderate pediatric asthma, IM dexamethasone appears to be as effective as 3 to 5 days of oral prednisone or prednisolone.

Oral single dose

Intramuscular dexamethasone injections are painful and can be difficult to administer, so oral administration is a preferred route, especially owing to a suggested 80% bioavailability.12

One study followed up with 110 children at 5 days after randomization to either a single dose of oral dexamethasone (0.6 mg/kg, maximum 18 mg) or oral prednisolone (1 mg/kg per dose, maximum 30 mg) twice daily for 5 days. Overall hospital admission rates at 5 days were 9 of 56 for dexamethasone and 10 of 54 for prednisolone (P = .80).13 Patient self-assessment scores done twice daily show a median of 5 days to return to baseline in both groups.

Brown et al14 reviewed 672 patient records to assess the effect of adding oral dexamethasone to the emergency department triage standing orders for patients with asthma presenting with an exacerbation. The addition of early oral dexamethasone at triage was associated with a lower admission rate: 24% before versus 17% after (P = .017).

Compliance

The compliance rates following emergency department visits for both general pediatric prescriptions15 and asthma-control medications16 are suboptimal. Single-dose treatment given in the ambulatory care setting might improve compliance.

Most of the single-dose dexamethasone studies point out its compliance advantage over multiple days of prednisone. In a study from Vancouver, BC, 10 of 261 families never filled their prednisone prescriptions, despite the fact that doing so was part of the terms they had agreed to for the study and despite being informed that there would be follow-up questions about taking the medicine.2 In a study from the US Army Medical Center in Hawaii,9 3 of 17 children receiving prednisone refused more than 75% of their doses and 4 additional children missed at least 30% of their doses. As many as 70% of the parents of children receiving either oral prednisone or IM dexamethasone said they would prefer the IM injection for their children’s next asthma exacerbations.

Acceptability

Any move to an oral preparation, especially in the pediatric population, must take into account palatability of the medication. In a single-blind taste test among 39 children 5 to 12 years old, the palatability of dexamethasone was significantly better than that of prednisolone (8.2 cm vs 5.0 cm on a 10-cm visual analogue scale; P = .03).17 Furthermore, the relatively smaller volume of a dexamethasone dose allows its taste to be masked easily with flavoured syrup.

Incidence of vomiting was also raised as a concern with prednisone and prednisolone preparations. Kim et al reported an 18% vomiting rate for generic prednisolone versus a rate of 5% for the better-tasting prednisolone sodium phosphate oral solution formulation in 188 children.18 In contrast to the frequent emesis seen with prednisolone, dexamethasone is considered to have an antiemetic effect. Indeed, anesthesiologists use it frequently as a postoperative antiemetic,19 and oncologists sometimes use it to minimize chemotherapy-related vomiting.20

Direct studies of dexamethasone for asthma support its tolerability. No vomiting was reported after an oral dexamethasone dose in a study of 61 children.13 Another study reported 1 (0.3%) case of emesis with dexamethasone versus 11 cases (3%) with prednisone (P = .008).2 Finally, when emergency physicians substituted oral dexamethasone for prednisone in triage, poststeroid emesis was reduced from 27 of 336 cases to 0 (P < .001).14

Conclusion

Growing evidence suggests that single-dose dexamethasone (oral or IM) for mild-to-moderate pediatric asthma exacerbation is as effective as multiday prednisone regimens, with better taste and improved compliance. Larger-scale studies, including those to determine the safest and most effective dose, are still needed in order to build confidence in a single-dose approach for children with mild-to-moderate asthma.

Notes

PRETx

Child Health Update is produced by the Pediatric Research in Emergency Therapeutics (PRETx) program (www.pretx.org) at the BC Children’s Hospital in Vancouver, BC. Drs Cross and Paul are members and Dr Goldman is Director of the PRETx program. The mission of the PRETx program is to promote child health through evidence-based research in therapeutics in pediatric emergency medicine.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in children? We invite you to submit them to the PRETx program by fax at 604 875-2414; they will be addressed in future Child Health Updates. Published Child Health Updates are available on the Canadian Family Physician website (www.cfp.ca).

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. National Heart, Lung, and Blood Institute
    . Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report 2007. Washington, DC: US Department of Health and Human Services; 2007. Available from: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed 2011 Jun 20.
  2. ↵
    1. Qureshi F,
    2. Zaritsky A,
    3. Poirier MP
    . Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr 2001;139(1):20-6.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Greenberg RA,
    2. Kerby G,
    3. Roosevelt GE
    . A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. Clin Pediatr (Phila) 2008;47(8):817-23. Epub 2008 May 8.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Arguedas A,
    2. Emparanza P,
    3. Schwartz RH,
    4. Soley C,
    5. Guevara S,
    6. de Caprariis PJ,
    7. et al
    . A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 2005;24(2):153-61.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Melby JC
    . Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Intern Med 1974;81(4):505-12.
    OpenUrlPubMed
  6. ↵
    1. Czock D,
    2. Keller F,
    3. Rasche FM,
    4. Häussler U
    . Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005;44(1):61-98.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Chang AB,
    2. Clark R,
    3. Sloots TP,
    4. Stone DG,
    5. Petsky HL,
    6. Thearle D,
    7. et al
    . A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust 2008;189(6):306-10.
    OpenUrlPubMed
  8. ↵
    1. Klig JE,
    2. Hodge D 3rd.,
    3. Rutherford MW
    . Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. J Asthma 1997;34(5):419-25.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Gries DM,
    2. Moffitt DR,
    3. Pulos E,
    4. Carter ER
    . A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr 2000;136(3):298-303.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Gordon S,
    2. Tompkins T,
    3. Dayan PS
    . Randomized trial of single-dose intramuscular dexamethasone compared with prednisolone for children with acute asthma. Pediatr Emerg Care 2007;23(8):521-7.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Vega R,
    2. Babata KL,
    3. Cayo JS,
    4. Piya A,
    5. Kumar Swayampakula A,
    6. Neugebauer R
    . Comparing parental satisfaction between intramuscular dexamethasone and oral prednisolone for asthma exacerbations in children. Paper presented at: Pediatric Hospital Medicine 2011; 2011 Jul 27–31; Kansas City, MO.
  12. ↵
    1. Duggan DE,
    2. Yeh KC,
    3. Matalia N,
    4. Ditzler CA,
    5. McMahon FG
    . Bioavailability of oral dexamethasone. Clin Pharmacol Ther 1975;18(2):205-9.
    OpenUrlPubMed
  13. ↵
    1. Altamimi S,
    2. Robertson G,
    3. Jastaniah W,
    4. Davey A,
    5. Dehghani N,
    6. Chen R,
    7. et al
    . Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care 2006;22(12):786-93.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Brown KM,
    2. Sun SL,
    3. Teach SJ,
    4. Chamberlain JM
    . Addition of a standing order for oral dexamethasone to an emergency department asthma pathway is associated with improved patient outcomes. Paper presented at: Pediatric Academic Societies Annual Meeting; 2010 May 1–4; Vancouver, BC.
  15. ↵
    1. Kajioka EH,
    2. Itoman EM,
    3. Li ML,
    4. Taira DA,
    5. Li GG,
    6. Yamamoto LG
    . Pediatric prescription pick-up rates after ED visits. Am J Emerg Med 2005;23(4):454-8.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Boychuk RB,
    2. DeMesa CJ,
    3. Kiyabu KM,
    4. Yamamoto FY,
    5. Sanderson RR,
    6. Gartner BM,
    7. et al
    . Emergency department discharge asthma plans modestly improve controller medication compliance in persistent asthmatics. Paper presented at: American Academy of Pediatrics National Conference and Exhibition; 2004 Oct 9; San Francisco, CA.
  17. ↵
    1. Hames H,
    2. Seabrook JA,
    3. Matsui D,
    4. Rieder MJ,
    5. Joubert GI
    . A palatability study of a flavored dexamethasone preparation versus prednisolone liquid in children. Can J Clin Pharmacol 2008;15(1):e95-8. Epub 2008 Feb 1.
    OpenUrlPubMed
  18. ↵
    1. Kim MK,
    2. Yen K,
    3. Redman RL,
    4. Nelson TJ,
    5. Brandos J,
    6. Hennes HM
    . Vomiting of liquid corticosteroids in children with asthma. Pediatr Emerg Care 2006;22(6):397-401.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Karaman M,
    2. Ilhan AE,
    3. Dereci G,
    4. Tek A
    . Determination of optimum dosage of intraoperative single dose dexamethasone in pediatric tonsillectomy and adenotonsillectomy. Int J Pediatr Otorhinolaryngol 2009;73(11):1513-5. Epub 2009 Jul 10.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Phillips RS,
    2. Gopaul S,
    3. Gibson F,
    4. Houghton E,
    5. Craig JV,
    6. Light K,
    7. et al
    . Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev 2010;(9):CD007786.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 57 (10)
Canadian Family Physician
Vol. 57, Issue 10
1 Oct 2011
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Single-dose dexamethasone for mild-to-moderate asthma exacerbations
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Single-dose dexamethasone for mild-to-moderate asthma exacerbations
Keith P. Cross, Ronald I. Paul, Ran D. Goldman
Canadian Family Physician Oct 2011, 57 (10) 1134-1136;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Single-dose dexamethasone for mild-to-moderate asthma exacerbations
Keith P. Cross, Ronald I. Paul, Ran D. Goldman
Canadian Family Physician Oct 2011, 57 (10) 1134-1136;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Effectiveness
    • Intramuscular single dose
    • Oral single dose
    • Compliance
    • Acceptability
    • Conclusion
    • Notes
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Single paternal Dexamethasone challenge programs offspring metabolism and reveals circRNAs as novel candidates in RNA-mediated inheritance
  • Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children
  • Outcomes for Pediatric Asthmatic Inpatients After Implementation of an Emergency Department Dexamethasone Treatment Protocol
  • Is Dexamethasone an Effective Alternative to Oral Prednisone in the Treatment of Pediatric Asthma Exacerbations?
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Child Health Update

  • Acute otitis media in children 6 months to 2 years of age
  • Erythema multiforme in children
  • Use of β2-agonists for viral bronchiolitis
Show more Child Health Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire